Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Whitepaper

Processability Assessment of Crystal Habit-Modified Active Pharmaceutical Ingredients

The efficiency of downstream processing of active pharmaceutical ingredients (API) can depend on their particulate properties, including size and shape.

Flowability and tabletability issues may be especially prominant in drug products with high API content, such as a crystal habit of an API. However, these can be adapted to the needs of downstream processing. Gamlen modified the needle-like crystal habits pf 5-ASA through direct compression using ring sheer testers, flow rate analysers, and instrumental tablet press.

Find out more about this case study, including the experiment results and powder and flow property assessments, download this free whitepaper.

Processability Assessment of Crystal Habit-Modified Active Pharmaceutical Ingredients

For Free, instant acess, click below.

Download Whitepaper

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.




Thank You

Your white paper is now downloading... Click here if the download does not begin.

Go Top